Search - tctmd.com

Displaying 41 - 60 of 63

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2018

Caitlin E. Cox

September 04, 2018

News Daily News

‘Doomed’ by Genetics? Lifestyle Still Matters in Preventing CVD and Diabetes

Yael L. Maxwell

June 29, 2018

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Shelley Wood

March 05, 2018

News Daily News

Roughly Half of Obese Patients Who Have Bariatric Surgery Are Off Type 2 Diabetes Meds at 6 Years

Michael O'Riordan

February 19, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for December 2017

Shelley Wood

December 28, 2017

News Daily News

Even After Recent ACS, Diabetic Patients With Multivessel Disease Fare Better With CABG

L.A. McKeown

December 11, 2017

News Conference News EuroPCR 2017

BIO-RESORT: Impaired Glucose Metabolism Linked With Worse Clinical Outcomes After PCI

Michael O'Riordan

May 18, 2017

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Daily News

Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label?

Yael L. Maxwell

December 23, 2016

News Daily News

Diabetes More Influential Than CAD Complexity in DES-Treated Patients

L.A. McKeown

February 03, 2016

News Daily News

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

August 27, 2015

News Conference News EuroPCR 2015

Evolving DES Technology May Benefit Diabetic Patients

Caitlin E. Cox

May 19, 2015

News Daily News

CREDO-Kyoto: Diabetic Patients With 3-Vessel or Left Main Disease Fare Better With CABG

February 08, 2015

News Conference News TCT 2014

Thoughtful Insights at TCT: Dealing With Complex CAD Cases

Todd Neale

October 17, 2014

News Daily News

CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term

Yael L. Maxwell

January 09, 2013

News Conference News AHA 2012

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Jason Kahn

November 11, 2012

News Daily News

PCI, Surgery Show Similar Long-term Mortality in Diabetic, Nondiabetic Patients

L.A. McKeown

August 15, 2012

News Daily News

La PCI y la Cirugía Confirman Mortalidad a Largo Plazo en Pacientes Diabéticos y No Diabéticos

L.A. McKeown

August 15, 2012

News Conference News

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

August 31, 2011

News Daily News

No Apparent Advantage for Everolimus vs. Paclitaxel Stents in Diabetic Patients

L.A. McKeown

August 19, 2011

Advertisement

TCTMD’s Top 10 Most Popular Stories for August 2018

‘Doomed’ by Genetics? Lifestyle Still Matters in Preventing CVD and Diabetes

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Roughly Half of Obese Patients Who Have Bariatric Surgery Are Off Type 2 Diabetes Meds at 6 Years

TCTMD’s Top 10 Most Popular Stories for December 2017

Even After Recent ACS, Diabetic Patients With Multivessel Disease Fare Better With CABG

BIO-RESORT: Impaired Glucose Metabolism Linked With Worse Clinical Outcomes After PCI

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label?

Diabetes More Influential Than CAD Complexity in DES-Treated Patients

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

Evolving DES Technology May Benefit Diabetic Patients

CREDO-Kyoto: Diabetic Patients With 3-Vessel or Left Main Disease Fare Better With CABG

Thoughtful Insights at TCT: Dealing With Complex CAD Cases

CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

PCI, Surgery Show Similar Long-term Mortality in Diabetic, Nondiabetic Patients

La PCI y la Cirugía Confirman Mortalidad a Largo Plazo en Pacientes Diabéticos y No Diabéticos

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

No Apparent Advantage for Everolimus vs. Paclitaxel Stents in Diabetic Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content